d-alpha tocopherol and finasteride

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

Topics: Androgen Antagonists; Cholesterol; Depression, Chemical; Diet; Eflornithine; Finasteride; Humans; Male; Prostatic Neoplasms; Retinoids; Vitamin E

Topics: 5-alpha Reductase Inhibitors; Aged; Animals; Clinical Trials as Topic; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Rabbits; Risk Factors; Selenium; Vitamin E

Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adenocarcinoma; Androgen Antagonists; Androgens; Animals; Anticarcinogenic Agents; Antioxidants; Carotenoids; Case-Control Studies; Cohort Studies; Dietary Fats; Double-Blind Method; Enzyme Inhibitors; Finasteride; Genetic Predisposition to Disease; Humans; Incidence; Insulin-Like Growth Factor I; Life Style; Lycopene; Male; Mice; Mice, Transgenic; Micronutrients; Neoplasms, Hormone-Dependent; Prospective Studies; Prostatic Hyperplasia; Prostatic Neoplasms; Racial Groups; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Soybean Proteins; Vitamin D; Vitamin E

Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Adult; Aged; Androgen Antagonists; Androgens; Anticarcinogenic Agents; Antioxidants; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diet; Double-Blind Method; Enzyme Inhibitors; Finasteride; Forecasting; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk; Selenium; Soybean Proteins; Treatment Outcome; Vitamin A; Vitamin D; Vitamin E

Topics: Anticarcinogenic Agents; Antioxidants; Azasteroids; Carotenoids; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Lycopene; Male; Prostatic Neoplasms; Vitamin E

Topics: Aged; Carotenoids; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Finasteride; Humans; Lycopene; Male; Middle Aged; Prevalence; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Tea; United States; Vitamin D; Vitamin E

Topics: 5-alpha Reductase Inhibitors; alpha-Tocopherol; Antineoplastic Agents, Hormonal; Diet, Fat-Restricted; Diet, Vegetarian; Enzyme Inhibitors; Finasteride; Genetic Therapy; Humans; Male; Neoadjuvant Therapy; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Selenium

Topics: 5-alpha Reductase Inhibitors; beta Carotene; Dairy Products; Diet, Fat-Restricted; Diet, Vegetarian; Enzyme Inhibitors; Exercise; Finasteride; Fish Oils; Humans; Life Style; Male; Meat; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Vitamin E

Topics: 5-alpha Reductase Inhibitors; Animals; Anticarcinogenic Agents; Azasteroids; Carotenoids; Dutasteride; Enzyme Inhibitors; Finasteride; Fishes; Flavonoids; Fruit; Humans; Isoflavones; Lycopene; Male; Neoplasms, Hormone-Dependent; Phenols; Polyphenols; Prostatic Neoplasms; Selenium; Soy Milk; Tea; Vegetables; Vitamin D; Vitamin E

Topics: Clinical Trials as Topic; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E

Topics: 5-alpha Reductase Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Azasteroids; Carotenoids; Chemoprevention; Clinical Trials as Topic; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E; Vitamins

Topics: Carotenoids; Drug Therapy; Enzyme Inhibitors; Finasteride; Humans; Isoflavones; Lycopene; Male; Prostatic Neoplasms; Selenium; Soy Foods; Vitamin A; Vitamin D; Vitamin E

Topics: Antineoplastic Agents; Azasteroids; Clinical Trials, Phase III as Topic; Dutasteride; Enzyme Inhibitors; Finasteride; Forecasting; Humans; Male; Prostatic Neoplasms; Selenium Compounds; Vitamin E

Topics: Androgens; Anticarcinogenic Agents; Azasteroids; Dutasteride; Finasteride; Humans; Male; Prostate; Prostatic Neoplasms; Selenium; Signal Transduction; Vitamin E

Topics: Aged; Azasteroids; Cholestenone 5 alpha-Reductase; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Toremifene; Vitamin E

Topics: Androgen Antagonists; Animals; Anticarcinogenic Agents; Antioxidants; Azasteroids; Carotenoids; Chemoprevention; Clinical Trials as Topic; Curcumin; Disease Models, Animal; Dutasteride; Finasteride; Flavonoids; Genistein; Humans; Lycopene; Male; Phytochemicals; Polyphenols; Prostate; Prostatic Neoplasms; Risk Factors; Selenium; Silybin; Silymarin; Tea; Vitamin E

Topics: 5-alpha Reductase Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Azasteroids; Carotenoids; Dietary Supplements; Dutasteride; Finasteride; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Lycopene; Male; Plant Extracts; Primary Prevention; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Selenium; Serenoa; Vitamin E

Topics: Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Finasteride; Humans; Inflammation; Male; Middle Aged; Prostatic Neoplasms; Selenium; Treatment Outcome; Vitamin E

Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Vitamin D; Vitamin E

Topics: Aged; Antioxidants; Enzyme Inhibitors; Finasteride; Humans; Incidence; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; United States; Vitamin E

Topics: Adult; Aged; Antioxidants; Clinical Trials as Topic; Dietary Supplements; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Sensitivity and Specificity; Vitamin E; Vitamins

Topics: Aspirin; Breast Neoplasms; Clinical Trials as Topic; Diet; Dihydrotestosterone; Female; Finasteride; Humans; Male; Neoplasms; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Tamoxifen; Vitamin E